These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 30275215)
1. Prognostic Significance and Clinicopathological Features of Synchronous Colorectal Cancer. Arakawa K; Hata K; Nozawa H; Kawai K; Tanaka T; Nishikawa T; Sasaki K; Shuno Y; Kaneko M; Hiyoshi M; Emoto S; Murono K; Sonoda H; Ishihara S Anticancer Res; 2018 Oct; 38(10):5889-5895. PubMed ID: 30275215 [TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients? Kim HJ; Kim N; Choi YJ; Yoon H; Shin CM; Park YS; Lee HS; Ahn SH; Park do J; Kim HH; Son IT; Kang SB; Lee DH Gastric Cancer; 2016 Jul; 19(3):798-807. PubMed ID: 26445944 [TBL] [Abstract][Full Text] [Related]
3. Prognostic Impact of Histologic Type in Curatively Resected Stage IV Colorectal Cancer: A Japanese Multicenter Retrospective Study. Shibata J; Kawai K; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Hata K; Nozawa H; Kazama S; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Sugihara K; Watanabe T Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S621-9. PubMed ID: 26350364 [TBL] [Abstract][Full Text] [Related]
4. Prognosis of synchronous colorectal carcinoma compared to solitary colorectal carcinoma: a matched pair analysis. He W; Zheng C; Wang Y; Dan J; Zhu M; Wei M; Wang J; Wang Z Eur J Gastroenterol Hepatol; 2019 Dec; 31(12):1489-1495. PubMed ID: 31441800 [TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Synchronous Colorectal Adenocarcinoma: A Matched-Pair Analysis. Anannamcharoen S; Nimmanon T; Cheeranont P; Boonya-Ussadorn C Asian Pac J Cancer Prev; 2024 May; 25(5):1539-1545. PubMed ID: 38809625 [TBL] [Abstract][Full Text] [Related]
6. Preoperative Neutrophil-to-Lymphocyte Ratio is a Better Prognostic Serum Biomarker than Platelet-to-Lymphocyte Ratio in Patients Undergoing Resection for Nonmetastatic Colorectal Cancer. Choi WJ; Cleghorn MC; Jiang H; Jackson TD; Okrainec A; Quereshy FA Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S603-13. PubMed ID: 25900206 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic features of synchronous colorectal carcinoma: A distinct subset arising from multiple sessile serrated adenomas and associated with high levels of microsatellite instability and favorable prognosis. Hu H; Chang DT; Nikiforova MN; Kuan SF; Pai RK Am J Surg Pathol; 2013 Nov; 37(11):1660-70. PubMed ID: 23887157 [TBL] [Abstract][Full Text] [Related]
9. Regional Lymph Nodes Status and Ratio of Metastatic to Examined Lymph Nodes Correlate with Survival in Stage IV Colorectal Cancer. Ahmed S; Leis A; Chandra-Kanthan S; Fields A; Zaidi A; Abbas T; Le D; Reeder B; Pahwa P Ann Surg Oncol; 2016 Jul; 23(7):2287-94. PubMed ID: 27016291 [TBL] [Abstract][Full Text] [Related]
10. [Clinicopathological analysis of 39 patients with multiple primary synchronous colorectal carcinoma]. Fang P; Qian F; Wu JZ Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Nov; 10(6):535-9. PubMed ID: 18000774 [TBL] [Abstract][Full Text] [Related]
11. Synchronous and metachronous colorectal cancers: distinct disease entities or different disease courses? Huang CS; Yang SH; Lin CC; Lan YT; Chang SC; Wang HS; Chen WS; Lin TC; Lin JK; Jiang JK Hepatogastroenterology; 2015; 62(138):286-90. PubMed ID: 25916050 [TBL] [Abstract][Full Text] [Related]
12. Treatment and Outcome of Synchronous Colorectal Carcinomas: A Nationwide Study. Bos ACRK; Matthijsen RA; van Erning FN; van Oijen MGH; Rutten HJT; Lemmens VEPP Ann Surg Oncol; 2018 Feb; 25(2):414-421. PubMed ID: 29159744 [TBL] [Abstract][Full Text] [Related]
13. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers. Nakamura M; Miyamoto S; Maeda H; Zhang SC; Sangai T; Ishii G; Hasebe T; Endoh Y; Saito N; Asaka M; Ochiai A Clin Cancer Res; 2004 Dec; 10(24):8434-41. PubMed ID: 15623623 [TBL] [Abstract][Full Text] [Related]
14. Colorectal obstruction is a potential prognostic factor for stage II colorectal cancer. Okuda Y; Shimura T; Yamada T; Hirata Y; Yamaguchi R; Sakamoto E; Kataoka H Int J Clin Oncol; 2018 Dec; 23(6):1101-1111. PubMed ID: 29948240 [TBL] [Abstract][Full Text] [Related]
15. Advanced Mucinous Colorectal Cancer: Epidemiology, Prognosis and Efficacy of Chemotherapeutic Treatment. Ott C; Gerken M; Hirsch D; Fest P; Fichtner-Feigl S; Munker S; Schnoy E; Stroszczynski C; Vogelhuber M; Herr W; Evert M; Reng M; Schlitt HJ; Klinkhammer-Schalke M; Teufel A Digestion; 2018; 98(3):143-152. PubMed ID: 29870979 [TBL] [Abstract][Full Text] [Related]
16. Synchronous and Metachronous Colorectal Cancers: Distinct Disease Entities or Different Disease Courses? Huang CS; Yang SH; Lin CC; Lan YT; Chang SC; Wang HS; Chen WS; Lin TC; Lin JK; Jiang JK Hepatogastroenterology; 2015 Jun; 62(140):838-42. PubMed ID: 26902012 [TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological studies and patterns of recurrence of mucinous colorectal carcinoma with curative resection]. Higuchi T; Kobayashi H; Ishikawa T; Ishiguro M; Iida S; Uetake H; Enomoto M; Sugihara K Gan To Kagaku Ryoho; 2010 Nov; 37(12):2560-2. PubMed ID: 21224639 [TBL] [Abstract][Full Text] [Related]
18. Is there a prognostic value of tumor location among Chinese patients with colorectal cancer? Liu F; Li C; Jia H; Yang L; Wu Y; Zhao J; Cai S; Zhu J; Xu Y Oncotarget; 2017 Jun; 8(24):38682-38692. PubMed ID: 28418874 [TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in the patients with T2N0M0 colorectal cancer. Xu B; Yu L; Zhao LZ; Ma DW World J Surg Oncol; 2016 Mar; 14():76. PubMed ID: 26965721 [TBL] [Abstract][Full Text] [Related]
20. A high preoperative carbohydrate antigen 19-9 level is a risk factor for recurrence in stage II colorectal cancer. Nozawa H; Ishihara S; Kawai K; Hata K; Kiyomatsu T; Tanaka T; Nishikawa T; Otani K; Yasuda K; Sasaki K; Murono K; Watanabe T Acta Oncol; 2017 May; 56(5):634-638. PubMed ID: 27885879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]